Olli Kallioniemi

14PUBLICATIONS
63CO-AUTHORS
Molecular targetsHaematological tumoursMedical mycologyTumour immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Oct 19, 2024
Distinct molecular profiles and shared drug vulnerabilities in pancreatic metastases of renal cell carcinoma.

Matilda Roos-Mattila, Pauliina Kallio, Tamara J Luck

|Mar 05, 2024
Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed Myeloblasts.

Elyse A Olesinski, Karanpreet Singh Bhatia, Chuqi Wang

|Mar 06, 2023
Stromal FAP Expression is Associated with MRI Visibility and Patient Survival in Prostate Cancer.

Teijo Pellinen, Kevin Sandeman, Sami Blom

|Aug 17, 2022
Multiomics characterization implicates PTK7 in ovarian cancer EMT and cell plasticity and offers strategies for therapeutic intervention.

Juuli Raivola, Alice Dini, Hanna Karvonen

|Jun 22, 2018
Immune cell contexture in the bone marrow tumor microenvironment impacts therapy response in CML.

Oscar Brück, Sami Blom, Olli Dufva

|Feb 07, 2018
ITGB1-dependent upregulation of Caveolin-1 switches TGFβ signalling from tumour-suppressive to oncogenic in prostate cancer.

Teijo Pellinen, Sami Blom, Sara Sánchez

Pageof 3

Frequent Collaborators

4 joint publications

S Eldfors

3 joint publications

Riku Turkki

3 joint publications

Tuomas Mirtti

2 joint publications

Sami Blom